🔎 Trials Near Me

ホーム › 卵巣がん

米国で参加者を募集している卵巣がんの臨床試験

米国全土の拠点で、卵巣がんに関する263件の研究が参加者を募集しています。

最も多くの研究がある都市

州別

最近更新された研究

公式研究テキスト（英語）

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

被験者募集中観察研究
2歳〜100歳 · 全性別 · 2026/10/02更新 · NCT01950572

Distance-Based Exercise to Preserve Function and Prevent Disability

被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

被験者募集中第1相
18歳〜120歳 · 全性別 · 2026/10/02更新 · NCT04847063

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

被験者募集中第1相
18歳〜120歳 · 全性別 · 2026/10/02更新 · NCT06885697

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

被験者募集中観察研究
3歳以上 · 全性別 · 2026/10/02更新 · NCT01441089

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

被験者募集中第2相
18歳〜72歳 · 全性別 · 2026/10/02更新 · NCT01174121

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

被験者募集中第2相
18歳以上 · 女性 · 2026/10/01更新 · NCT07024784

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07189871

TLR9 Immunotherapy for Peritoneal Carcinomatosis

被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07658196

Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer

被験者募集中第3相
18歳以上 · 女性 · 2026/10/01更新 · NCT07851025

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

被験者募集中
18歳以上 · 全性別 · 2026/10/01更新 · NCT04751435

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07285044

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07278336

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07814248

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07360314

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06799065

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT05128825

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。